Cardiopulmonary exercise testing is a viable method for diagnosing the heart condition and other cardiopulmonary traits. The test method incorporates checking the blood pressure, conducting the electrocardiography examination, and so on. Such tests are commonly practiced in developing nations attributable to the increasing health awareness among the individuals. This describes the exponential development of cardiopulmonary exercise testing in global regions like North America. The increasing prevalence of various cardiovascular diseases has led to an enhancement in the cardiopulmonary exercise testing in different global regions. The availability of the top-notch healthcare system has made the cardiopulmonary exercise testing highly competent in the global market. The global cardiopulmonary exercise testing market is projected to reach the valuation of USD 2248.21 Mn by growing at a CAGR of 5.75% during the forecast period (2018- 2023).
Download Free Sample Pages of this report
The global cardiopulmonary exercise testing market is segmented on the basis of its product, end-user and regional demand. Based on its product, the global market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Stress Blood Pressure Monitors, Pulse Oximeters, Echocardiogram, Others. On the basis of its end-users, the market is classified into ambulatory centers, hospitals and clinics, diagnostic centers and others.
Geographically, the global cardiopulmonary exercise testing market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
COSMED srl, Masimo Corporation, GE Healthcare, Cardinal Health, Halma plc., Koninklijke Philips N.V., Hill-Rom Holdings, Inc., Schiller AG and Vyaire Medical, Inc, MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, among others are some of the major players in the global cardiopulmonary exercise testing market.